日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol

奥拉帕尼用于携带同源重组修复基因改变的肿瘤患者:药物再发现方案的结果

Spiekman, Ilse A C; Mehra, Niven; Zeverijn, Laurien J; Geurts, Birgit S; Verkerk, Karlijn; Haj Mohammad, Soemeya F; van der Noort, Vincent; Roepman, Paul; de Leng, Wendy W J; Jansen, Anne M L; van de Luijtgaarden, Addy C M; van Voorthuizen, Theo; Buffart, Tineke E; Gelderblom, Hans; Voest, Emile E; Verheul, Henk M W

Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk

最初诊断为非高危神经母细胞瘤但最终发展为高危临床病程的分子特征

Bruinsma, Rixt S; de Leng, Wendy W J; Fiocco, Marta F; Dierselhuis, Miranda P; Langenberg, Karin P; Molenaar, Jan J; Kester, Lennart A; van Noesel, Max M; Tytgat, Godelieve A M; van de Ven, Cornelis P; Wijnen, Marc H W A; de Krijger, Ronald R; Steeg, Alida F W van der

Evaluation of homologous recombination testing in ovarian carcinoma

卵巢癌同源重组检测的评价

Witjes, Vera M; de Hullu, Joanne A; van Remortele, Angela; Vreede, Lilian; Rosenberg, Efraim H; Cillessen, Saskia A G M; Groenendijk, Floris H; Steeghs, Elisabeth M P; Moonen, Laura; Mensenkamp, Arjen R; Ter Elst, Arja; de Leng, Wendy W J; Hoogerbrugge, Nicoline; Ligtenberg, Marjolijn J L

Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours

MAP2K1突变型原发性皮肤黑色素细胞肿瘤的临床结果和基因组特征

Ebbelaar, Chiel F; Jansen, Anne M L; Speet, Leonie C M; Schutgens, Frans; Zoetemeyer, Sietske; Cleton-Jansen, Anne-Marie; van Dijk, Marijke R; Breimer, Gerben E; Bloem, Lourens T; de Leng, Wendy W J; van Doorn, Remco; Suijkerbuijk, Karijn P M; Schrader, Anne M R; Blokx, Willeke A M

The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP)

通路改变负荷是靶向治疗疗效的泛癌决定因素:药物再发现方案(DRUP)的结果

Verkerk, K; Zeverijn, L J; van de Haar, J; Roepman, P; Geurts, B S; Spiekman, A C; van der Noort, V; van Berge Henegouwen, J M; Hoes, L R; van der Wijngaart, H; Jansen, A M L; de Leng, W W J; Gelderblom, A J; Verheul, H M W; Voest, E E

Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics

利用新型检测方法对实体瘤进行全面的基因组分析,以用于临床诊断中的广泛分析

Froyen, Guy; Volders, Pieter-Jan; Geerdens, Ellen; Berden, Severine; Van der Meulen, Joni; De Cock, Aaron; Vermeire, Stefanie; Van Huysse, Jacques; de Barsy, Marie; Beniuga, Gabriela; de Leng, Wendy W J; Jansen, Anne M L; Demers, Imke; Ozgur, Zeliha; Dubbink, Hendrikus Jan; Speel, Ernst-Jan M; van IJcken, Wilfred F J; Maes, Brigitte

Students' perspective on new teaching concepts for medical studies: case- and competency-based learning in radiology

学生对医学学习新教学理念的看法:放射学中的案例式和能力式学习

Masthoff, Max; Pawelka, Friedrich; Zak, Gisela; de Leng, Bas; Darici, Dogus; Schindler, Philipp; Heindel, Walter; Helfen, Anne

Ameloblastic Fibro-Odontoma with an FGFR1 Mutation: A Case Report

伴有FGFR1突变的成釉细胞纤维牙瘤:病例报告

Aouam, Oumaima; Janssen, Nard G; de Leng, Wendy W J; Breimer, Gerben E

Joint online distance learning to complement postgraduate pathology training in preparation for national board examinations

联合开展在线远程学习,以补充研究生病理学培训,为国家执业资格考试做准备。

de Leng, Bas; Helle, Laura; Jokelainen, Otto; Kainulainen, Mikko; Kronqvist, Pauliina; Mol, Christian; Pawelka, Friedrich; Pohjanen, Vesa-Matti; Vincken, Koen

Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4

成人弥漫性、IDH野生型胶质瘤,组织学改变轻微,TERT启动子突变孤立:并非单纯的WHO 4级中枢神经系统胶质瘤

Priesterbach-Ackley, L P; Cordier, F; de Witt Hamer, P; Snijders, T J; Robe, P A; Küsters, B; de Leng, W W J; den Dunnen, W F A; Brandsma, D; Jansen, C; Wesseling, P; Muhlebner, A